Search
Transgender Women Benefit from Prostate Cancer Screenings
Transgender women keep their prostates after gender-affirming surgery, and as a result are still at risk for prostate cancer.Renowned Urologic Specialist to Lead UCSF Urology Program
Benjamin N. Breyer, MD, MAS, FACS, a renowned leader in urology and urological surgery, has been appointed chair of the UCSF Department of Urology.Low-Risk Differentiated Thyroid Cancer Case Studies: Patient-Centered Approaches to Treatment
A 2022 UCSF study found that, since publication of the 2015 American Thyroid Association (ATA) guidelines, surgeons nationwide are performing more thyroid lobectomies for low-risk differentiated thyroid cancer (DTC) proportional to other thyroid surgeries for the condition.Focused Ultrasound Stops Tremors in Patients with Movement Disorders: UCSF Case Studies
High-intensity focused ultrasound (HIFU) is an incision-free, minimally invasive outpatient procedure during which MRI-guided ultrasound is directed at the ventral intermediate (VIM) nucleus of the thalamus.UCSF Internal Medicine Specialist Celebrated for Diabetes Epidemiology Research
Alka M. Kanaya, MD, UC San Francisco primary care physician and researcher, has been honored with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA).Can Reducing Insulin Resistance Minimize Severe Asthma Symptoms?
UCSF researchers led a study that found insulin resistance (IR) is common in patients with severe asthma and is associated with lung function impairment and suboptimal responses to asthma medications.Scientists Discover a Deadly Brain Cancer’s Hidden Weakness
The difficult-to-treat brain cancer glioblastoma steals a person’s mental faculties as it spreads, yet the tumor’s insidious ability to infiltrate distant networks in the brain could also prove its undoing.UCSF Surgical Oncologists Providing New Treatment Options for Patients with Metastatic Gastrointestinal Cancers
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.There’s a More Humane Way to Monitor Crohn's and Colitis Patients
IBD, which comprises Crohn’s disease and ulcerative colitis, affects 1.3% of the U.S. population and accounts for 3 million new diagnoses every year.Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
New data from a clinical trial show therapies may activate lymph nodes to produce tumor-tackling T cells.Personalizing Prostate Cancer Screening May Improve the Accuracy of Detection
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer.UCSF’s First Medical Director of Robotic Surgery on Improving Patient Outcomes and Enabling Innovation
Thoracic surgeon Johannes Kratz, MD, has been selected as UCSF’s first medical director of robotic surgery.UCSF’s Division of Cardiology to Partner with Rosenman Institute
UC San Francisco’s Division of Cardiology has joined with the Rosenman Institute to speed the development of health-tech innovation at UCSF.New ATS Recommendation: Use Race-Neutral Equations for Pulmonary Function Test Interpretation to Improve Patient Care
An American Thoracic Society (ATS) workshop committee, which included many UCSF researchers, recently released an official statement recommending the use of race-neutral average reference equations for pulmonary function test (PFT) interpretation.First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.Advanced Heart Failure Clinic at Walnut Creek
Through a collaboration between John Muir Health and UCSF Health, patients with advanced heart failure have access to specialized care in Walnut Creek.Alcohol-Associated Liver Disease Program
UCSF HEPATOLOGY AND LIVER TRANSPLANT SERVICES have established the Alcohol-Associated Liver Disease Program, expanding access to hepatology care and liver transplantation for a broader range of patients.Interventional Cardiology Program
The UCSF Interventional Cardiology Program offers the latest minimally invasive catheter-based procedures to diagnose and treat the full spectrum of cardiovascular conditions.Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer Patients
Led by a multidisciplinary team of specialists and researchers, our program optimizes the cardiovascular health of cancer patients and cancer survivors.Novel Tricuspid and Mitral Valve Procedures Improve Patients' Quality of Life
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed two novel minimally invasive cardiac procedures for the first time in the health system.Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find
Patients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.Chances of Receiving Percutaneous Coronary Intervention in a Low-Volume Facility are Increasing, Despite Worse Outcomes
There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes.Susceptibility to Pathogenic T Cells in Chronic Lung Disease May have a Genetic Basis
Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue, and leading to one of the most common diagnoses for hospital admissions.UCSF Surgical Oncologists Present Clinical Findings at International Conference
The latest advances in surgical cancer care and research were showcased at the Society of Surgical Oncology’s (SSO) Annual Meeting, the International Conference on Surgical Cancer Care. The meeting was held in Boston, from March 22 – 25, 2023.